[Gonadotropic function during its use and after its cessation of a triphasic combination of gestodene].
The present data show that the contraceptive studied, a triphasic combination pill with gestodene, strongly depresses gonadotropin levels. Seric levels of both FSH and LH are below 1 mIU/ml as early as the third treatment cycle. Recovery of a normal pituitary function occurs rapidly after the administration is discontinued: both basal and stimulated gonadotropin levels are back to normal during the first cycle following a 3 months treatment course. Prolactin secretion remains unaltered both during and after treatment.
D000328:Adult; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D006062:Gonadotropins / Q000097:blood*; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000097:blood; D009652:Norpregnenes / Q000494:pharmacology*; D045167:Progesterone Congeners / Q000494:pharmacology*; D011388:Prolactin / Q000097:blood
D003276:Contraceptives, Oral; D006062:Gonadotropins; D009652:Norpregnenes; D045167:Progesterone Congeners; C033273:Gestodene; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone
Etude de la fonction gonadotrope pendant l'utilisation et après l'arrêt d'une association triphasique au gestodène.